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Genetic and environmental conditions lead to global changes in the chemical com-
position of biological systems. The extended analysis of cellular metabolic pathway
products gives insights into the functionality of enzymes in normal and pathological
conditions. In the last years, metabolomics acquired an important role in detecting
prognostic factors for various diseases including polycystic kidney disease.
Effective methods employed for metabolomic studies are nuclear magnetic resonance
(NMR) spectroscopy and coupling two-dimensional gas chromatography with time-of-
flight mass spectrometry (GC×GC-TOF-MS). For both technologies, software exists
that detects signals within the raw data as candidates for metabolites. Some of these
candidates are verified as metabolites by comparison to a metabolite library, many
remain unknown. The metabolite candidates and the number of metabolite candid-
ates vary across different measurements. While NMR covers up to 150 metabolites,
GC×GC-TOF-MS detects thousands of metabolites in one measurement. Hence,
combining different meseaurements by GC×GC-TOF-MS is ambitious and required
to apply statistical methods and machine learning techniques.
Thus, we developed the integrative normalization and comparative analysis software
tool INCA. INCA automatically identifies equal metabolite candidates among differ-
ent measurements and combines them into one data matrix. The alignment algorithm
is validated by an spike-in experiment and successfully applied to various metabolo-
mic datasets. A commercial software tool was provided one year after completion of
INCA. It is based on similar parameters and performs comparable.
Not only the detection of new prognostic factors is of interest but also the prediction of
treatment response or disease status. Autosomal polycystic kidney disease (ADPKD)
is a frequent cause of kidney failure. It is usually diagnosed at a progressed stage
of renal cystic transformation due to a lack of reliable laboratory tests early in the
disease. Hence, the prognosis of patients to develop ADPKD is challenging.
In terms of classification, prognosis is associated with the probability for developing
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the disease. Healthy patients and patients where the disease is reliably diagnosed are
used to learn a classifier. This classifier consists of a set of features that defines a
decision rule separating the healthy from the diseased, and assigning a new patient
to the correct class with high probability. In microarray based classification, the
performance of classification algorithms has been analyzed in great detail. However,
little attention has been given to the usefulness of probability estimates and this is
even more true for metabolomic analyses. Thus, I developed probability estimation
methods based on local errors and compared them to existing methods from gene
expression profiling, text categorization and digit recognition.
I show that the local error based methods perform superior to more widely used
methods, the PAM program, binary regression, and Compound Bayes classifiers. Es-
pecially the PAM approach performs poorly because its probability estimates depend
on the number of selected features. I recommend not to make use of these estimates
in the context of clinical diagnosis of patients. Although the estimators are evaluated
on metabolomics data, I believe that similar results are obtained for different forms
of clinical diagnosis based on high dimensional readouts, e.g. proteomic or transcrip-
tomic profiling data. From the perspective of probability estimation the effective
dimensionality is that of the feature signature and not that of the original data set.
The dimensionality of gene expression based signatures described in the literature is
well comparable to the metabolomics dataset.
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Most of the probability estimation methods are used in combination with different
classifiers for gene expression data. Thus, I developed my local error based estimation
methods on microarray datasets.
Chapter 1 starts with an introduction to transcriptomic and metabolomic data.
The metabolomics techniques nuclear magnetic resonance spectroscopy and two-
dimensional gas chromatography mass spectrometry are described in more detail.
In Chapter 2, classification algorithms and existing probability estimation methods
from different fields are reviewed.
The alignment algorithm INCA for two-dimensional gas chromatography mass spec-
trometry data is presented and evaluated in Chapter 3 together with its applications
and a comparison to a commercial software tool.
Finally, my local error based probability estimation methods are defined and com-




Genetische Faktoren und Umwelteinflu¨sse vera¨ndern die chemischen Zusammenset-
zung biologischer Systeme global. Eine detaillierte Analyse zellula¨rer Stoffwechsel-
produkte bei normalen und pathologischen Bedingungen gibt Einblicke in die Funk-
tionalita¨t von Enzymen und anderen Metaboliten. In ju¨ngster Zeit erfa¨hrt die Un-
tersuchung von Metaboliten und deren Zusammenspiel bei der Detektierung pro-
gnostischer Faktoren verschiedenster Krankheiten, wie zum Beispiel Zystennieren,
erho¨hte Aufmerksamkeit.
Nukleare Magnetresonanzspektroskopie (NMR) und das Koppeln von zwei-dimen-
sionaler Gaschromatographie an Flugzeitmassenspektrometrie (GC×GC-TOF-MS)
werden erfolgreich bei metabolomischen Studien angewandt. Fu¨r beide Technologien
gibt es Software, die in den Rohdaten potentielle Metabolite identifiziert. Einige
dieser Kandidaten werden durch einen Abgleich mit einer Datenbank als Metaboli-
te erkannt, viele bleiben unbekannt. Die Metabolitkandidaten und die Anzahl der
Metabolitkandidaten ist in verschiedenen Messungen unterschiedlich. NMR kann
bis zu 150 Metabolite in einer Messung identifizieren, GC×GC-TOF-MS mehrere
Tausend. Das Verknu¨pfen verschiedener Messungen ist somit eine Herausforderung,
aber unumga¨nglich vor dem Auswerten der Daten mittels statistischer Methoden und
Techniken des maschinellen Lernens.
Zu diesem Zweck habe ich die Software INCA, kurz fu¨r ”Integrative Normalization
and Comparative Analysis”, entwickelt. INCA erkennt automatisch gleiche Meta-
bolitkandidaten u¨ber verschiedene Messungen hinweg und fasst diese in einer Daten-
matrix zusammen. Der Alignmentalgorithmus wird durch ein Spike-In Experiment
validiert und erfolgreich auf verschiedene metabolomische Datensa¨tze angewendet.
Ein Jahr nach der Vero¨ffentlichung von INCA wurde von Dritten eine kommerzielle




Nicht nur die Identifizierung neuer prognostischer Faktoren ist wichtig, sondern auch
das Vorhersagen einer Therapieantwort oder des Krankheitsstadiums. Autosomale
polyzystische Nieren (ADPKD) sind ein ha¨ufiger Grund fu¨r Nierenversagen. In der
Regel wird die Krankheit erst in einem fortgeschrittenen Stadium der Zystennieren-
transformation diagnostiziert. ADPKD bei nierenkranken Patienten fru¨h zu diagnos-
tizieren ist eine Herausforderung.
Im Bereich Klassifikation wird die Prognose mit der Wahrscheinlichkeit assoziiert
zu erkranken. Messungen von gesunden und kranken Patienten werden benutzt um
einen Klassifikator zu lernen. Dieser Klassifikator besteht aus einer Menge von Ei-
genschaften, die die gesunden von den kranken Patienten trennt, und einen neuen Pa-
tienten mit hoher Wahrscheinlichkeit in die richtige Klasse einordnen kann. Bei der
Klassifikation von Microarraydaten ist die Performance der Klassifikationsalgorith-
men bereits detailliert untersucht. Jedoch wurde die Verla¨sslichkeit von gescha¨tzten
Wahrscheinlichkeiten besonders bei metabolomischen Analysen wenig untersucht. Ich
habe Scha¨tzmethoden fu¨r Diagnosewahrscheinlichkeiten entwickelt, die auf lokalen
Fehlern basieren, und mit bekannten Methoden verglichen, die aus den Bereichen
der Mustersuche in Genexpressionsdaten, Textkategorisierung und Ziffernerkennung
stammen.
Ich zeige, dass Methoden, die auf lokalen Fehlern basieren, besser sind als weit ver-
breitete Methoden, wie das PAM Programm, bina¨re Regression und Compound-
Klassifikatoren. Besonders PAM schneidet schlecht ab, da seine Wahrscheinlich-
keiten von der Anzahl der ausgewa¨hlten Eigenschaften abha¨ngt. Ich empfehle diese
Scha¨tzungen nicht im Kontext klinischer Diagnose von Patienten zu verwenden. Im
Rahmen dieser Arbeit werden die Scha¨tzer auf metabolomischen Daten ausgewer-
tet und verglichen. Trotzdem lassen sich a¨hnliche Resultate fu¨r verschiedene For-
men von klinischer Diagnose hochdimensionaler Daten, zum Beispiel proteomische
oder transkriptomische Daten zur Mustersuche, erzielen. Von der Perspektive des
Wahrscheinlichkeitscha¨tzens ist die effektive Dimensionalita¨t der Genexpressionssig-






This thesis addresses the prediction of metabolomic and transcriptomic patient pro-
files. The analysis of metabolomics data is an emerging field whereas the analysis
of transcriptomic data using microarrays is well-elaborated. We developed a software
tool that is able to combine metabolomics two-dimensional gas chromatography mass
spectrometry measurements containing different features and numbers of features.
Subsequently, the combined data are used to identify potential novel biomarkers for
disease states (see Chapter 3). At time of development almost no software solutions
were available. This chapter gives an overview on transcriptomic and metabolomic
data (Sections 1.1 and 1.2). The focus will be on metabolomic data since analyses
throughout my thesis are applied to this type of data (see Section 1.3).
1.1 From the genome to the metabolome
The genome is the complete genetic hereditary information of an organism, and serves
as blueprint for all cellular processes. Almost each cell of an organism stores a full
copy of the genome. It is encoded in DNA, deoxyribonucleid acid, which consists of
four building blocks, the nucleotides. Connected by sugar and phosphate, they form
a single DNA chain. Two chains run in opposite directions to each other building a
double helix.
The DNA is copied in small stretches, called transcripts (or messanger RNA), and
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Figure 1.1: The ”omics”-cascade: From genotype to phenotype.
further translated into cellular protein molecules. The translation process is determ-
ined by the genetic code: nucleotide triplets are transformed into 20 different amino
acids, the building blocks of proteins. A stretch of DNA coding for a protein is called
gene. A gene is expressed if it is copied or transcribed. The whole pool of transcripts
in a cell constitutes the transcriptome and reflects the genes that are being actively
expressed at any time.
Depending on the environment, proteins determine the metabolic capabilities of the
cell. In contrast to the genome, the transcriptome and proteome react more easily to
external environmental conditions.
Finally, the metabolome captures the network of metabolic reactions of a cell, and
refers to the complete set of small molecules. These include sugars, amino acids,
lipids, other small-molecule metabolites, and signalling molecules.
Dettmer et al. [20] summarize the relationships of the genome, transcriptome, pro-
teome, and metabolome in the ”omics”-cascade (see Figure 1.1).
The cascade also shows the relationship between genotype and phenotype. The gen-
otype is implied by the set of all genes within a cell. Depending on the environmental
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influences, it determines the morphological and physiological phenotype. Hence, ge-
nomics addresses the genotype whereas metabolomics researches into the phenotype
of an organism.
1.2 What can be measured?
A variety of well established as well as still developing technologies is available for
each ”omics”-science.
Genomics Important techniques associated with genomics involve various sequen-
cing methods. On the level of DNA, single genes or whole genomes are read and
compared. Variations of single sequence positions and deletions, insertions or inver-
sions of longer stretches of DNA within a gene can lead to expression changes of
many other genes. This in turn can cause cancer. A prominent example is the breast
cancer gene BRCA1, which helps to repair damaged DNA or to destroy cells if DNA
cannot be repaired (reviewed by Venkitaraman [64]).
Besides sequencing DNA, the amino acid sequence of a protein can be determined to
discover its structure and function.
Transcriptomics Measuring gene expression is based on the complementary bind-
ing properties of DNA to DNA or DNA to RNA. Genome-wide gene expression
changes are measured using the microarray technology. Thousands of spots of dif-
ferent DNA sequences are located on a microarray, each part of a particular gene.
Thus, thousands of genes can be analyzed simultaneously and searched for signific-
antly different expression patterns among various conditions or tissues. Differentially
expressed genes may be targets for drug development [13, 41] or new biomarkers
which can be used to describe a certain tissue or disease state [37, 46, 60].
Proteomics and Metabolomics Proteins and other biomolecules are encoded
in genes and therefore may be just as well biomarkers or drug targets. The struc-
tures of proteins can be analyzed using X-ray crystallography, the abundances using
mass spectrometry (MS) or nuclear magnetic resonance (NMR) spectroscopy meth-
ods. Whereas X-ray crystallography is capable of analyzing large proteins and is often
used for drug design, the latter methods focus on the analysis of biological fluids and
the comparison of disease states or tissues to get insights into signalling pathways,
or to detect novel biomarkers. An example within the area of drug design is the
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structure of FK506-binding protein (FKBP) which forms a complex with ascomycin,
an immunosuppressant [10]. A study of urine NMR data identified drug metabol-
ites in common use in a sample of the U.S. human population, in particular, from
acetaminophen and ibuprofen metabolites [34].
1.3 Measuring the metabolome
Metabolomics aims at the comprehensive quantitative analysis of all metabolites in
a biological system [2]. It investigates metabolic changes caused by disease, environ-
mental or genetic factors in an organism. This is challenging since the metabolome
comprises thousands of small molecules present over a wide range of different con-
centrations [20, 21]. The number of metabolites varies among organisms and sample
types. The prokaryote E. coli contains about 750 metabolites [48], whereas eukaryotic
systems range from several thousands in humans [68] up to hundreds of thousands
in various plant species [31, 50]. The main analytical techniques employed for meta-
bolomic studies are based on nuclear magnetic resonance (NMR) spectroscopy and
mass spectrometry (MS) [39].
In NMR spectroscopy a sample is exposed to a electromagnetic field. Atoms with spe-
cific nuclear properties (like 1H, 13C and 31P ) absorb electromagnetic radiation and
emit a resonance frequency depending on the strength of the magnetic field and their
position in the molecule. This frequency is recognized by a detector and translated
to a single data signal using Fourier transformation. An example spectrum of a urine
sample is shown in Figure 1.2. The Fourier-transformed signals (x -axis) are plotted
against their intensities (y-axis). A compound consists of one or more intensity sig-
nals: citrate is represented by 4 signals, whereas formate has only one signal. Signals
overlay and are disturbed by the water signal. 20 to 100 metabolites are identified
in one measured NMR sample. Wishart estimates the number of metabolites for a
sample to a maximum of 150 [69]. The need for high concentration levels limits the
detection of metabolites. Concentrations must be in the range of µg/ml. Thus, NMR
can detect hydrophilic compounds like sugars, amines and volatile ketones.
In mass spectrometry, the sample is vaporized (transferred to the gas phase), and the
components of the sample are ionized and depending on the ionization used broken
down into fragment ions by a ion source. The ions are separated according to their
mass-to-charge ratio and recorded as different mass traces by a detector. To get rid
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Figure 1.2: In a one-dimensional nuclear magnetic resonance (1D-NMR) spectrum
of a urine sample Fourier-transformed signals are plotted against their signal
intensities. The unit of measurement is parts per million (ppm).
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of overlaying signals, metabolic components are pre-separated by either gas chroma-
tography (GC), or liquid chromatography (LC). For GC, the components must be
transferred to and maintained in the gas phase. This requires a sufficient vapor pres-
sure. To extend the range of metabolites amenable to GC analysis derivatization can
be performed to reduce the polarity and boiling point of the analytes. Frequently,
silylation (here adding a trimethylsilylester group) in combination with methoxima-
tion is used for metabolic fingerprinting [30]. The sample is vaporized in an injector
and sent through a silica capillary, the column, which is coated with the stationary
phase, in most cases a highly viscous liquid. The metabolites leave the column at
different time points depending on their vapor pressure and in case of polar station-
ary phases depending on their vapor pressure and polarity. Subsequently, they are
detected by the mass spectrometer. A GC-MS chromatogram (see Figure 1.3) shows
signal intensities of metabolites (y-axis) arriving at different time points at the de-
tector (x -axis). Each data point represents a mass spectrum, which is the sum of all
fragment ions and their intensities of a metabolite. The time is called retention time.
In analogy to NMR, one metabolite consists of several signals and signals overlay. The
detection limits of MS range from pg/ml to µg/ml. GC-MS methods concentrate on
hydrophobic compounds and provide up to 2000 metabolites per measurement which
corresponds to the number of human metabolites currently known [20].
MS is 10-fold more sensitive and covers much more metabolites per measurement
than NMR. Both methods produce a spectrum. The ionisation destroys the metabol-
ites, in NMR the sample can be measured several times. Choosing a metabolomics
method depends on the substances to be measured, and their concentrations. Both
methods are used for the comparative analysis of biological fluids like urine, serum
or other tissue extracts.
The comparative analysis of disease states requires the identification of informative
signals. The chemometric approach directly compares raw spectra to identify relevant
spectral features. Each spectrum is divided into bins and a spectral feature is given
by the area under the spectrum for each bin. These features are then used to identify
the corresponding metabolites. In metabolomics the metabolites of each measure-
ment are identified by comparing the raw spectra to a spectral reference library first.
Subsequently, these metabolites are searched for biomarkers or informative pathways
[69, 25]. The discovery of novel compounds as biomarker candidates is also called
metabolic profiling, the detection of diagnostic pathways metabolic fingerprinting.
22
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Figure 1.3: A one-dimensional gas chromatography mass spectrometry (1D-GC-
MS) chromatogram shows signal abundances for different time points depending
on the arrival of the metabolite at the detector.
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1.4 Metabolomics using two-dimensional gas
chromatography time-of-flight mass spectrometry
data
Comprehensive two-dimensional gas chromatography (GC×GC) is suited for the ana-
lysis of complex samples [15, 1]. It offers a multiplicative increase in peak capacity
by combining two columns with a thermal or flow based modulator, with thermal
modulators being more prevalent. The thermal modulator focuses the sample from
the first column periodically by freezing and heating in small segments that are then
transferred to the second column [16, 9] (see Figure 1.4). This yields a second di-
mension retention time, a wider separation space, very narrow peaks, and thus, lower
limits of detection. A chromatogram is commonly visualized by a two-dimensional
plot where the axes denote the retention times and a color code the peak intensities
(Figure 1.5). Blue indicates no signal, red high intensity. In the figure, the signal
intensity is the total ion count of all fragment ions for a metabolite. A chromatogram
can be plotted for each fragment ion separately as well. For broader signals is not
clear whether more than one metabolite is present, e.g. the signal left of succinate.
Many signals are less intensive and may or may not be a true metabolite. The set
of all identified signals are defined as metabolite candidates. The term peak also
refers to a metabolite candidate. These have to be evaluated using a database of
identified metabolites or by an expert manually. Coupled to an electron ionization
time-of-flight mass spectrometer (TOF-MS) for metabolite identification, GC×GC
has been applied successfully to metabolic fingerprinting [36, 44, 35, 28]: the detec-
tion of changes among different conditions, like disease states or tissues.
Before comparing measurements, metabolite candidates within each chromatogram
have to be identified and combined across chromatograms. The metabolite candidates
and the number of metabolite candidates vary across measurements. Some may be
present in the disease state, but not in the control sample. The presence of thousands
of metabolite candidates per measurement calls for automatic solutions.
Different solutions have been suggested in recent years for the alignment and pro-
cessing of GC×GC-TOF-MS spectra. Shellie et al. [57] directly compare chroma-
togram plots of mouse tissue extracts. First, all peaks in the chromatograms are
represented by bubbles. Bubble plots of mutant as well as control mice are averaged.
Further, the bubbles of the control mice plot are subtracted from the bubbles of the
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Figure 1.4: Schematic view of a two-dimensional gas chromatography time-of-
flight mass spectrometer: The sample is injected, runs through the first column,
is freezed and heated in small segments in the modulator before entering the
second column (GC×GC), and finally gets ionized and is measured by the de-
tector (TOF-MS).
mutant mice. Finally, the remaining peaks, which are identified as metabolites, are
sorted in decreasing order of their bubble size. The parallel factor analysis (PAR-
AFAC) algorithms [43, 6] use raw chromatographic data as input. Factor models
search for consistent signals across samples for metabolite identification, alignment,
and quantification of spectra. These complex models are computing-intensive.
Peaks across different measurements may be shifted because of a varying injection
time or temperature. Therefore, Fraga et al. [24] and van Mispelaar et al. [62] propose
algorithms to correct retention time variations in comprehensive two-dimensional
separations. Both methods can only be applied to small regions of interest in two-
dimensional data sets. A retention time correction of the entire chromatogram in
both separation dimensions is described in Pierce et al. [52] and by Zhang et al. [73].
Pierce et al. adjust peak shifts using reference peaks in windows of first and second
dimension retention times across samples. The correlation optimized warping (COW)
algorithm of Zhang et al. corrects time shifts and combines measurements in one step
by dividing the chromatogram plots into smaller squares. These are stretched and
compressed such that standard peaks overlay across measurements. The overlap is
25
Chapter 1 Comparing metabolomics and microarray data
Figure 1.5: A two-dimensional chromatogram plot where the axes describe the
retention times generated by the two columns. The color encodes the peak
intensities with blue indicating no signal against background, and red high in-
tensity. In this figure, the signal intensity is the total ion count of all fragment
ions for a metabolite. Plotting a specific fragment ion is possible as well.
measured by correlation. Alternatively, Schmarr et al. [56] apply an image processing
approach that is routinely used in the comparison of two-dimensional protein gels for
the compensation of run-to-run variations and peak merging.
The methods mentioned so far align raw GC×GC-TOF-MS data based on two-
dimensional retention times, ignoring the specific fragment ion mass spectrum of a
metabolite. They ignore viable data preprocessing functions, provided by the instru-
ment software - for instance by ChromaTOF, such as peak finding, peak integration,
library search and signal-to-noise filtering. Oh et al. [49] developed the MSort soft-
ware for GC×GC-TOF-MS data that uses data processing provided by the Leco
ChromaTOF software to generate peak tables. The algorithm creates a reference
table of metabolite candidates using first and second dimension retention times and
the linear correlation of fragment mass spectra. Peaks not present in a large number
of samples are excluded from alignment. Then, the reference peaks are searched and
combined across all samples. Peaks not present in the reference table are lost. The
calculation of all pairwise correlations requires a lot of computer memory. Wang
et al. [65] propose a distance and spectrum correlation optimization (DISCO) al-
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gorithm that uses the Euclidean distances of standardized two-dimensional retention
times and the correlation of mass spectra for peak alignment. It works similar to my
alignment algorithm [4] (INCA) developed one year before.
INCA sorts metabolite candidates into an alignment table according to tolerance
parameters for retention times and mass spectra. The tolerance parameters may be
set by the user or can be optimized by spiked-in metabolites. No metabolite can-
didates are lost during alignment. A detailed description of INCA alignment and
applications is given in Chapter 3. In 2010, Leco provided their own commercial
alignment tool Statistical Compare (SC). It is implemented in the Leco ChromaTOF
software version 4. We compared SC to the in-house developed algorithm INCA (see
Chapter 3).
Recently, Castillo et al. provided a open source data analysis platform called Guineu
[11]. Guineu uses peak lists and performs data alignment based on retention times
and mass spectral information.
The Statistical Compare alignment tool of Leco company The description of
the Statistical Compare alignment tool is based on information received from Leco.
Many details are missing and cannot be recovered.
In the Statistical Compare (SC) feature of ChromaTOF, peaks are aligned based on
first (1st) and second (2nd) dimension retention times and mass spectra. Pairwise
sample comparisons of all samples are made peak by peak. Peaks across samples
will be grouped together if they are within a specified retention time window and
share the best spectral match. The spectral match uses the match algorithm from
the National Institute of Standards and Technology (NIST), the same algorithm that
is used in library searches.
Following the pairwise comparisons, common peaks are linked from sample to sample
to create groups of common analyte peaks. During the grouping conflicts may arise
due to the parameters specified in the data processing method (retention time window
and mass spectral match threshold) or variability in peak interferences and retention
time shifts. The software takes various steps encoded in non-accessible source code
to resolve these conflicts. Failure to resolve conflicts results in the exclusion of peaks
from the final table.
To assign a name to an entry in the aligned peak table, the peak of each sample gets a
peak weight. This weight is based on the peak shape of an extracted mass ion, which
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is unique for that peak, and the quality of the found peak. The best quality peak
within a group of aligned peaks is selected to conduct a library search for that group
of peaks. The name of the matching library compound appears in the compound
table.
Peak finding performed during data preprocessing may yield different unique masses
for identical compounds in different samples. However, SC has to choose a mass
for quantification from the unique masses. The quant mass is a mass that uniquely
identifies a metabolite in a specified retention time window. This quant mass is the
most common unique mass for the peak across all samples. If a different unique mass
has been selected for an analyte in any of the samples, the peak profile of the specified
quant mass is checked. If the peak profile is good, the quant mass is used. If the
peak profile is poor, the profile of the unique mass is used and the ratio of the quant
mass to the unique mass in the peak true spectrum is multiplied by the unique mass
peak profile to produce the quant mass peak profile for calculating the peak height
and peak area. In a summary, if the unique masses of a identical compound across
samples differ, the peak area of the differing compound is interpolated.
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Review on classification probabilities
In this chapter I explain the concepts of classification algorithms (Section 2.1) and
motivate classification probabilities (Section 2.2). Existing estimation methods for
pairs of disease states in the context of computer-based learning are reviewed in Sec-
tion 2.3. These probability estimation methods involve parameters, which need to be
trained. Together with parameters of the classification procedure I discuss the whole
training and validation framework in Section 2.4.
2.1 Classification of ”omics” data
In supervised learning, feature selection, classification, and model selection are closely
connected. A decision rule, also called the classifier, is inferred from training data
where class membership is known. This rule is applied to new data to predict class
membership. The classifier is based on a set of features. In metabolomics, these
features are metabolite candidates, in transcriptomics gene expression profiles which
are able to separate healthy patients from patients of known disease (see Figure 2.1).
The metabolite candidates or the gene signature are choosen according to a quality
criterion like the maximal classification accuracy. The classes are disease entities,
such as leukemia subtypes [29], risk groups [63], treatment response [12] or disease
outcome [67].
Both, metabolomics and transcriptomics datasets, comprise less measurements than
measured features. Ion abundances of a metabolite or gene expression values are
continuous variables. Hence, the learning concepts developed for transcriptomics data
can be applied to metabolomics data. In microarray based classification, a variety
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Figure 2.1: Healthy and diseased patients are used to learn a gene signature which
is able to separate the two groups with small misclassification error. Transcrip-
tomic data are arranged in a matrix where the rows correspond to genes and
columns to patients. The gene signature is colored in blue and yellow indicat-
ing different levels of gene expression. The samples of unknown group label are
predicted as healthy if their expression profile of the signature genes is similar
to the expression profiles within the healthy group.
of classification algorithms have been proposed and critically compared [14, 23, 72].
Examples are neural networks, support vector machines, ridge regression, variants of
linear discriminant analysis (LDA) such as Fisher’s LDA or diagonal LDA, decision
trees, and nearest neighbour approaches.
Typically, the discriminating genes are selected before learning a classifier (filter
methods) or in combination with the classification algorithm (wrapper and embed-
ded methods) [55, 72]. Filter methods rank genes using statistical measures or tests
such as Fisher’s ratio, t-statistics, χ2-statistic, information gain, or Pearson’s cor-
relation. The top ranked genes with highest classification accuracy are selected as
gene signature. Afterwards, a classifier predicts new patients based on the fixed set
of signature genes. Wrapper methods directly employ a classifier for assessing the
diagnostic information of genes. The genes are weighted: the better the ability to
separate the healthy from the diseased patients, the higher the weight of the gene.
Those with lowest weights are iteratively excluded (recursive feature elimination),
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Figure 2.2: The gene expression levels of two genes span a two-dimensional space.
Healthy (green dots) and diseased (blue dots) patients are separated by a gray
line. On the left panel, patients are separated by a linear boundary with some
misclassifications. The right panel shows a more complex boundary which does
not make errors on the training data. The new patient (red dot) is predicted as
healthy but is located next to the diseased patients. Intuitively, he should be
predicted as diseased.
or those with highest weights are iteratively added to the gene signature (forward
feature selection), as long as the classification accuracy increases. While weights are
fixed for filter methods, they are iteratively adjusted for wrapper methods. While
filter methods consider each gene separately, wrapper methods take interactions or
coexpression of genes into account. Wrapper methods search heuristically for signa-
ture genes. Embedded methods are coupled to a classifier which selects the genes to
infer the optimal decision boundary.
In general, classification methods can be distinguished in linear and non-linear mod-
els [40] (see Figure 2.2). Linear models base their prediction of a new patient on
weighted genes. These weights define a boundary hyperplane between healthy and
diseased patients of the training data. In Figure 2.2, the left panel shows the linear
separation (gray line) of healthy (green dots) and diseased (blue dots) patients. The
two-dimensional space is spanned by the gene expression levels of two genes. The
two classes can not be separated without misclassifications. One diseased patient is
located within the healthy group and some healthy patients within the diseased. The
more complex boundary of a non-linar model on the right panel does not make any
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errors, but the new patient (red dot) is predicted as healthy, although it is nearer to
the diseased patients and intuitively, should be predicted as diseased.
The training data is a sample from the whole population of healthy and diseased
patients. The classifier applies to the whole population. The complex model fits the
training data but the misclassification rate on new patients nevertheless might be
much higher than that of simpler models (see also Wessels et. al [66]). A misclassi-
fication rate for new patients can be estimated by putting a part of the training data
aside as test set. The classifier is learned on the training set and applied to the test
set offering a classification accuracy which can be used as an estimation whether a
new patient is predicted correctly. If the training set is partitioned into k parts and
each part is taken apart once as test set, this loop is called cross-validation. For more
details on training and testing, the reader is referred to Section 2.4.
2.2 Why probabilities?
Diagnosis, prognosis and prediction of treatment response based on transcriptomic,
proteomic or metabolomic profiles is a well developed field [58, 42]. It very much
depends on the classification problem at hand, whether an almost error free classifier
can be developed or whether some classification errors are unavoidable regardless of
what algorithm is chosen.
In the latter case it is natural that a clinician asks for the reliability of an individual
diagnosis before moving on to treatment decisions. Classification algorithms are
typically evaluated by the frequency of misclassifications in cross-validation or on an
independent test set. However, these performances are averages over many predicted
cases. They tell little about the reliability of an individuals diagnosis. The case might
be easier or more difficult to diagnose than the average in the test set. Reliability
of individual classifications can be expressed in terms of classification probabilities.
For each case, every class is assigned a value pj ∈ [0, 1]. This value is an estimated
probability that the case belongs to that class, given the profiling data available for
the given case.
In microarray based classification, the performance of classification algorithms has
been analyzed and compared in great detail [22, 66]. However, little attention has
been given to the usefulness of probability estimates and this is even more true
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for metabolomic analyses. In fact, only relatively few classification algorithms for
genomic and metabolomic profiles estimate class probabilities and in the majority of
clinical papers on the performance of classifiers such case specific probabilities are
not shown.
One reason for the limited use of probability estimates in genomics might be that they
are hard to validate. While classifications are either right or wrong, it is less clear
whether a classification probability is correct or incorrect. The probability estimates
typically rely on model assumptions that vary across classification models, which
makes them difficult to compare. Nevertheless, one can ask the question: When is
a classification probability useful? I argue that it is most useful, if it flags incorrect
classifications as low confidence classifications. In other words: if a classifier produces
confident class probabilities close to one, these should be correct classifications.
2.3 Probability estimators
In the next paragraphs, a selection of class probability estimators is reviewed in-
cluding the estimator from the popular prediction analysis for microarrays (PAM)
program [60] and methods more widely used in different application areas like text
categorization and digit recognition.
Notations: Let xij be a data matrix with i = 1, 2, . . . ,m denoting features (meta-
bolites) and j = 1, 2, . . . , n denoting cases. Further let Ck be a vector storing the
true class membership (disease types) of cases with k ∈ 1, 2.
The end product of all linear classification algorithms is a classification rule that
assigns a case to class 1 if s(x) < 0 and otherwise to class 2, where x = (x1, x2, . . . , xp)
is the vector of intensity values of p signature features, w = (w1, w2, . . . , wp) a vector
of corresponding feature weights, and s(x) =< w, x > −b with distance to the origin
b. Note that the vector w spans a line orthogonal to the separating hyperplane,
< w, x > is the orthogonal projection of profile x onto this line, and s(x) the distance
of x to the hyperplane. Intuitively, cases that are closer to the separating hyperplane
are less reliably classified than those that are further away.
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Naive Bayes Estimates (NB) Tibshirani et al. [60] proposed a method for class
prediction in DNA microarray studies based on nearest shrunken centroids. Each
class k is represented by a shrunken centroid x¯k and a case x is assigned to the
class with the nearest centroid. By shrinking standard class centroids to the overall
centroid less-informative genes are weighted down or filtered out, thus yielding sparse






− 2 · logpik
is calculated independently for each class, where the sum runs over all genes with
non-zero weights after shrinkage ∆, σi is the pooled within-class standard deviation of
gene i, and pik the estimated proportion of cases from class k in the entire population.
A case is then assigned to the group k with minimal δk(x). Classification probabilities
are also derived from the δk(x) by assuming independence and normality with equal
within-class variance of all p classifier genes. Under these assumptions Bayes’ theorem













Note that the nearest shrunken centroid classification rule defines a separating hy-
perplane with normal vector wi =
2·(x¯i2−x¯i1)
σ2i







The proof of the transformation of Equation 2.1 can be found in Appendix A.1. In this
approach every gene in the classifier is assumed to contribute independent evidence
as to whether the case x belongs to class k or not. This assumption is mostly not
justified biologically and produces artifacts that will be discussed in Chapter 4.
Compound Bayes Estimates (CB) Another type of class probability estimators
that is used for microarray classification problems is the Compound Bayes estimator.
It was introduced in Wright et al. [70] and was used for classifying diffuse large B-
cell lymphoma (DLBCL) into two biologically and clinically distinct subgroups called
ABC and GCB lymphomas, and a class of ”unclassifiable” cases, which comprises all
cases with borderline classification probabilities. It needs to be noted that the classes
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ABC and GCB were defined from the gene expression data in an unsupervised analysis
which puts the analysis outside of our supervised classification context. Nevertheless,
the estimator can be applied in a supervised setup without modification. In line
with the PAM approach, the CB estimator models both classes individually using
normal distributions. However, unlike the PAM approach, the CB estimator models
the one-dimensional distributions of the projected data s(xj) instead of the multi-
dimensional distributions of the original data xj. Given a separating hyperplane with
normal vector w and associated classification scores s(xj) = 〈w, xj〉 − b, one assumes
that the s(xj) are distributed normally in both classes with possibly different means





φ1(s(x); µˆ1, σˆ21) + φ2(s(x); µˆ2, σˆ
2
2)
where φ(x;µ, σ2) represents the normal density function with mean µ and variance
σ2. The four parameters µˆ1, µˆ2, σˆ1, σˆ2 are estimated from the projected data s(xj).
Both methods above model distributions for both classes separately and invoke Bayes
theorem to obtain class probabilities. A well established complementary approach is
the direct estimation of class probabilities through binary regression. The approach
has many ramifications some of which have been applied to genomic data [67, 18].
Binary Regression (BReg) In the evaluation of probability estimation functions,
the class of binary regression models is represented by the approach described in




by minimizing a cross-entropy error function to adjust the parameters A and B. Al-
though Platt [53] uses this estimator in combination with linear and non-linear sup-
port vector machines, it can also be used together with our linear classifiers without
changes, since the regression simply operates on a set of precalculated classification
scores s(xj) without exploiting any properties implied by the method that generated
these scores.
The three estimators described so far are parametric in that they assume that the
data is generated according to certain parametrized families of distributions (normal
35
Chapter 2 Review on classification probabilities
Figure 2.3: The Figure shows class probability functions (CPFs) for probability
estimation methods Naive Bayes, Compound Bayes, Binary Regression and Local
Error Frequencies using binning.
distributions) or in that the regression function is known (logistic) up to some ad-
justable parameters. In the next paragraph, a non-parametric estimator based on
monotone regression will be described.
Local Error Frequencies (LEF(Bin)) If the shape of the regression function that
relates classification scores to class probabilities is unknown, it can be estimated from
local misclassification frequencies. Zadrozny et al. [71] sort cases by the scores s(xj)
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and split them into equally sized disjoint bins. The local class k frequency Fk(x)
of case x is then calculated as the relative frequency of class k cases that fall into
the same bin as x. The local error frequencies can be interpreted as the classifica-
tion performance of the algorithm given the distance to the separating hyperplane.
Naturally it becomes smaller in bins closer to the decision boundary. However, the
estimates Fk(xj) do not need to be strictly monotonous in s(xj). Hence, and perhaps
counter-intuitively, in a few cases that are closer to the separating hyperplane might
be judged more reliably classified than some of those that are further away from it.
To assure monotonicity of estimated probabilities with increasing score Zadrozny et
al. [71] use monotone regression as implemented in the pair-adjacent violators al-
gorithm (PAVA) [8]. PAVA yields the maximum likelihood estimates of the desired
probabilities by replacing Fk(xj) and Fk(xj+1) with their average when the mono-
tonicity constraint is violated. This averaging process is continued until an ordered
set of probabilities is obtained. As with previous methods it needs to be noted that
the original work by Zadrozny et al. [71] used the estimator in combination with a
different classification algorithm (decision trees). However, since this method is also
based only on post processing classification scores, it can be used in the linear clas-
sifier context as well. Examples for all class probability functions (CPFs) are shown
in Figure 2.3.
2.4 Training and validating class probability functions
In the previous section, procedures that estimate classification probabilities pk(xj)
from classification scores s(xj) were reviewed. The end product is always an estimated
class probability function (CPF) pk(s(x)) that maps the score s(x) to a number
between 0 and 1 that is interpreted as the probability that case x is in class k. The
CPF needs to be trained on sets of classification scores.
Training includes the estimation of distribution parameters like the class means and
variances in the Compound Bayes Estimator, the regression parameters A and B of
the binary regression approach, or the local error frequencies Fk(xj) and the non-
parametric regression curves resulting from monotone regression. In addition, train-
ing might depend on tuning parameters like the number of bins or the bandwidth of
a gaussian kernel, or the number of nearest neighbors in the adaptive LEF approach
(see Chapter 4).
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Figure 2.4: The Figure schematically shows a 3-fold nested cross-validation. In
the innermost loop the class probability function CPF is optimized, in the next
loop classifier sparsity is tuned and in the outermost loop validation is performed.
The different loops are marked by the size of the corresponding bars. Note that
in the Figure each loop is further separated into different rows to indicate that
data present in that loop are split several times in training and test data to
ensure that all data of a specific loop are used once for testing. The outermost
loop contains all data, of this the training data of the outermost loop are passed
to the middle loop where the passed data are split again in training and test
data and the training data of the middle loop are transfered to the innermost
loop where again a splitting in training and test data is performed.
Once a CPF is estimated, it can be used to predict classification probabilities of test
cases x′j by first calculating the scores s(x
′
j) using a linear classifier and then plugging
them into a CPF to gain the class probability pk(s(x
′
j)). This requires a CPF and a
classifier and both need to be previously learned from data. It is important that the
test cases x′j were not included in any of these learning processes.
With respect to CPF estimation it is important to distinguish between training scores
s(xj) and test scores s(x
′
j), since it is known that their distributions can be greatly
different [5]. Compared to test scores, training scores display a better but unrealistic
separation of classes. This overfitting phenomenon can greatly affect the estimated
CPFs as will be shown in Section 4.3. As an example, here a 3-fold nested cross-
validation is used that covers the processes of classifier estimation, CPF estimation,
parameter tuning, and evaluation. Parameters that need to be calibrated include the
tuning parameters of the local error frequency approach, which is called Θ and the
shrinkage parameter ∆ of the nearest shrunken centroid classification algorithm that
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controls the sparsity of the classifier.
1. CPF Estimation
In the inner-most loop the shrinkage parameter ∆ is fixed. N1 cases are left
out and the remaining cases are used to learn a classifier, which is applied
to the left out cases yielding scores s∆(xj). By leaving out all cases in turn,
cross-validated scores are achieved for all cases that entered the innermost cross-
validation loop. Note that these scores result from different classification rules
(learned hyperplanes) for different bins of left out cases. A CPF is estimated
from these scores for a variety of values of the parameter Θ. For each value
the p∆,Θk (xj) are computed using one of the methods described above. They
are evaluated with respect to their classification performance by calculating the
negative log-likelihood of true classes





log p∆,Θk (xj) (2.2)
The Θ with minimal − log(L) is chosen and the corresponding CPF p∆k (·) is
returned to the middle cross-validation loop.
2. Tuning Classifier Sparsity
In the middle loop, N2 cases are left out. The remaining cases are forwarded
to the inner loop varying ∆. For every ∆, the inner loop returns a CPF p∆k (·)
which is applied to the left out cases of the middle loop. These are evaluated by
their misclassification rate and the optimal value of ∆ and with it the optimal
number of features is determined. The optimized CPF pk(·) is returned to the
outer loop.
3. Validation
In the outer loop N3 cases are left out. The remaining cases are forwarded to
the middle loop, which returns a CPF pk(·) to be applied to the left out cases.
Finally, this leaves a set of cross-validated probabilities pk(xj) which will be
evaluated with respect to different criteria in Section 4.3.
Note that both the inner loop and the middle loop include internal loops that vary
the parameters Θ and ∆. However, these are not cross-validation loops, since they do
not involve leaving out additional cases. Clearly only the non-parametric estimators
based on local error frequencies include tuning parameters in CPF estimation. For
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all other methods there is no internal loop in the inner cross-validation. Moreover,
our design allows different CPF estimation procedures to use different numbers of
features for classification. This is enabled by the middle cross-validation loop. This
is important since some CPF estimators, for instance the PAM estimator, are very







In this chapter the preprocessing steps of two-dimensional gas chromatography time-
of-flight mass spectrometry (GC×GC-TOF-MS) data are described (Section 3.1).
This technology lacks in software to compare different measurements. Hence, we
developed an alignment algorithm (INCA) which combines measurements into one
data matrix (Section 3.2). The tool is validated by an spike-in experiment and ap-
plied to an E. coli dataset and a serum versus plasma sample collection. Recently, an
alignment algorithm has been integrated into the firm software package for the chro-
matograph (manufacturer Leco Corp.). We compare INCA to the new software tool
(see Section 3.3).
INCA and the comparison to the new software tool was performed in cooperation with
Martin F. Almstetter (Institute of Functional Genomics, Head Prof. Peter Oefner,
University of Regensburg). In his thesis, he focused on the experimental work related
to the validation and biomedical application of INCA whereas I focused on the bioin-
formatics work and, in particular, the development and validation of the algorithm.
The equal contributions to this body of research are documented in two joint first
authorships [4, 3].
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Figure 3.1: Linear models of first and second dimension retention times for a
GC×GC-TOF-MS measurement based on six odd-numbered fatty acids. A lin-
ear model consists of a scaling factor and an offset which best correlate the
observed retention times for the standards in the corresponding measurement to
the median across all measurements.
3.1 Data preprocessing
Raw data output from the mass spectrometer is processed with the Leco ChromaTOF
software. The validation and applications of INCA alignment is based on software
version 3.34 [4, 19], the comparison to the commercial software tool on version 4.32
[3]. Detailed parameter adjustments before processing can be found in Almstetter and
Appel et al. [4, 3] and are examined and optimized by Martin Almstetter. The result
of preprocessing is a peak list in tab-delimited format for each chromatogram con-
taining peak names or Unknown, first-dimension retention times, second-dimension
retention times, peak areas for the mass trace m/z 73 (m/z: mass to charge ratio),
and metabolite candidate mass spectra containing only fragment ions above a certain
intensity to reduce noise. The peak area of the mass trace m/z 73 that corresponds
to the trimethylsilyl cation is choosen because it is formed for each trimethylsilyl
derivative upon electron ionization. The signal to noise threshold is set to 500.
There are two types of technical variance in a measurement: variation in peak in-
tensity and retention time.
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The second type of variance influences the alignment process. Hence, it is adjusted
beforehand by two independent linear models for the first and second dimension reten-
tion time. The models are fitted on odd-numbered fatty acids included as standards
in each measurement. The fatty acids are well separated peaks that occur uniformly
over the entire separation range except for the early part of the chromatogram. There,
smaller odd-numbered fatty acids are not included as standards because of their nat-
ural occurrence in the biological matrix, here E. coli. A linear model consists of a
scaling factor and an offset for each measurement which best correlate the observed
retention times for the standards to the median across all measurements (see Figure
3.1). Multiplying by the scaling factor and adding the offset to the retention times
of all peaks compensate shifts.
The first type of technical variance does not influence the alignment algorithm and is
corrected afterwards. Small variations in peak intensity, for example caused by slight
changes in the amount of sample injected, are adjusted by an internal standard,
tridecanoic acid, present in all samples. The areas of all peaks are divided by the
area integral of the m/z 271 trace of tridecanoic acid for each measurement. Zero
values, which are introduced during alignment, are set to the minimum peak area
prior to log-transformation. Zero values result from (i) signals falling below the
predefined threshold of S/N 500, (ii) features not matching the tolerance parameters,
(iii) improper deconvolution of mass spectral signals due to signal saturation, and
(iv) failure of the ChromaTOF software to place peak markers.
3.2 Combining different measurements
After correcting for the main types of technical variance the retention time of the same
metabolite still varies across measurements. The preprocessing by the software also
includes sources of variance. The finding of metabolite peaks is not trivial because of
overlaying metabolite mass spectra. Thus, deconvoluted mass spectra slightly vary
in the number of fragment ions detected and relative signal intensities.
The biological and technical variance is taken into account by four tolerance paramet-
ers: one for each retention time, an overlap of fragment ions between mass spectra
and a tolerance for their relative intensities. The alignment algorithm starts with an
empty alignment matrix. The aligned metabolite candidates are arranged in rows,
their characteristics in the columns. Characteristics are intervals of retention times, a
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In i t i a l i z e th r e sho ld parameter t 1 s t , t 2nd , t o l , t r a t e
Aligned <− matrix ( ) # I n i t i a t e empty a l ignment matrix wi th
# columns ’Name’ , ’ r t 1 s t l o w e r b o u n d ’ ,
# ’ r t 1 s t u p p e r b o u n d ’ , ’ r t2nd lower bound ’ ,
# ’ rt2nd upper bound ’ , ’ spectrum S ’ ,
# areas f o r f i l e s , ’ mean rt1st ’ , ’ mean rt2nd ’
Peaks <− matrix ( measurements ) # Read raw data wi th columns ’Name’ ,
# ’ r t 1 s t ’ , ’ rt2nd ’ , ’ spectrum S ’ , ’ area ’
for each peak in Peaks :
i f Aligned i s EMPTY: generate new entry us ing peak ; next peak
r t 1 s t <− which ( abs ( Al igned$mean rt1st − peak$r t1s t ) <= t 1 s t )
i f any r t 1 s t :
rt2nd <−
which ( abs ( Aligned$mean rt2nd [ r t 1 s t ] − peak$rt2nd ) <= t 2nd )
i f any rt2nd :
for each S in Aligned$S [ r t 1 s t [ rt2nd ] ] :
i s <− dup l i ca t ed fragment i on s o f S$ ions and peak$ions
smal l e rS <− min ( l en (S ) , l en ( peak$S ) )
i f ( l en ( i s ) >= smal l e rS ∗ t o l :
h <− abs ( peak$S$h [ i s ] − S$h [ i s ] )
i f max(h) <= t r a t e : # a l i g n peak to Al igned entry
update r e t e n t i o n time boundar ies and means
update S as union s e t o f fragment i on s
and renorma l i z e he i gh t s
remember area at s p e c i f i e d f i l e p o s i t i o n
next peak
else : g enerate new entry us ing peak
Figure 3.2: Pseudocode of alignment algorithm. Parameters and associated
tolerances are t 1st and t 2nd which correspond to first and second dimension
retention times, while t ol and t rate correspond to relative overlaps of fragment
ions and their relative signal intensities for a given feature.
mass spectrum consisting of fragment ions, and an area detected for m/z 73 for each
measurement. The fragment ions of the mass spectrum are scaled so that the highest
abundance is 999. The default value for the areas detected for m/z 73 is zero.
To fill in the alignment matrix, the peak lists of all measurements are read into a raw
peak list. This list is sorted according to first followed by second dimension retention
times. Peaks are added one by one to the alignment matrix starting at the top of the
raw list. A raw peak is aligned to a metabolite candidate in the alignment matrix
if all tolerance parameters are satisfied. Otherwise a new candidate containing the
peaks retention times and spectrum is generated. A retention time is close enough
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Figure 3.3: Flowchart for automated preprocessing of GC×GC-TOF-MS data.
if its distance from the entrys corresponding mean of interval boundaries is smaller
than the corresponding tolerance parameter.
Two spectra are defined as similar if their fragment ions have a sufficient overlap and
the difference in ion abundances of the overlapping ions is small. Then, a new union
set of fragment ions and respective relative abundances is generated. Finally, the
appropriate area detected for m/z 73 is stored in the aligned data matrix. The toler-
ance parameters are choosen by the user or automatically adjusted using a standard
mixture added to each sample before measurement (see Section 3.3). The peak align-
ment module is implemented in R and accessed via the shell. The pseudo code can be
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found in Figure 3.2. The combined procedure of retention time correction and data
alignment is named INCA, integrative normalization and comparative analysis. A
flowchart including the automated preprocessing of GC×GC-TOF-MS data is shown
in Figure 3.3.
3.3 Validating the algorithm by a spike-in
experiment
Spike-in experiment A mixture of 20 metabolites is added to the extract of an E.
coli wildtype strain where the spiked-in metabolites do not naturally occur. These
are 2-hydroxybutyrate, 3-hydroxybutyrate, 2-hydroxy-3-methylbutyrate, 3-methyl-2-
oxovalerate, malonate, nicotinate, phenylacetate, dimethylsuccinate, decanoate, man-
delate, adipate, erythritol, phenyllactate, triethanolamine, dodecanoate, suberate,
xylitol, vannilate, mannitol, and eicosanoate. Seven spike levels are generated with
0.25, 0.275, 0.3125, 0.375, 0.5, 0.625, ad 1.0 nmol absolute of each analyte represent-
ing fold changes 1.1, 1.25, 1.5, 2.0, 2.5 and 4.0 by comparing all spike levels to the
base level 0.25. Each sample is prepared in six replicates and samples are measured
in random order. For correcting technical variance across measurements an internal
standard solution containing odd-numbered, saturated straight chain fatty acids (C9
- C19) is added to each sample.
Measuring failed for two samples of the highest spike level. These two are excluded
and the analysis is done based on 40 spike-in samples. The spike-in dataset is pre-
processed as described in Section 3.1. The peak list of a sample contain 500 to 1000
peaks.
Optimizing the tolerance parameters The tolerance parameters are set such that
the 20 spike-in metabolites are optimally aligned: the spike-ins are found and com-
bined across all measurements, and no false metabolite peaks are added to spike-in
entries in the alignment matrix. Due to a Leco software update in 2010, data pre-
processing and thus the optimization process is run for the validation of INCA [4]
(software version 3.34) and the comparison to the commercial software tool [3] (soft-
ware version 4.32).
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After preprocessing, the spike-in dataset is aligned using INCA for 288 different
parameter combinations (Table 3.1). In Almstetter and Appel et al. [4], sixteen
parameter settings are able to align the 20 standard compounds in a single row each,
yielding 800 out of 800 true positives. The optimal parameter setting is 8 seconds
and 0.1 seconds for the first and second dimension retention time, and 90% and 40%
overlap of m/z values and relative ion intensities.
Parameter Tolerance
t 1st [s] 4, 8, 12
t 2nd [s] 0.025, 0.05, 0.075, 0.1, 0.125, 0.15
t ol 1.0, 0.9, 0.8, 0.7
t rate 0.1, 0.2, 0.3, 0.4
Table 3.1: Parameters and associated tolerances tested for feature alignment.
t 1st and t 2nd are tolerances for the first and second dimension retention time
measured in seconds, t ol for the overlap of fragment ions and t rate for the ion
intensities.
For the optimal parameter setting the alignment matrix has 4726 metabolite candid-
ate entries. Many entries have only one or few non-zero values for the m/z 73 area.
These are assumed to be false peaks or noise. Thus, candidates detected in at least
50% of all samples are selected for further analysis. This peak reduction results in
517 peaks with 17% zero values. These peaks are assumed to be true metabolites.
This is highly compatible with multivariate analysis according to Gika et al. [26],
who suggested that up to 50% zero values are tolerated. Then, the peak areas are
normalized using tridecanoic acid and log transformed.
Furthermore, the spike-in dataset is used to check whether GC×GC-TOF-MS is able
to detect fold changes. When comparing the samples of two spike-in levels, only the
spike-in metabolites should vary. Differentially abundant metabolites are identified
using t-statistics assuming equal variance in both spike-in levels. T-statistics are
generated using the R Bioconductor package MULTTEST [54]. Sorting the list of
metabolites in decreasing order according to the absolute value of the t-statistic put
differential metabolites on top of the list. The spike-in metabolites should be found on
top and are counted as true positives. All other metabolites should be true negatives.
For each rank r of the sorted t-statistic, the sensitivity (true positive rate (TPR)) and
1 - specificity (false positive rate (FPR)) are calculated by comparing the metabolites
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down to rank r to the list of spike-ins. The efficiency across all ranks is illustrated
in receiver operating characteristic (ROC) curves. The false positive rate is plotted
against the true positive rate (Figure 3.4). The area under curve (AUC) is at most
1. If it is one the spike-in metabolites are found before all other metabolites.
GC×GC-TOF-MS is not able to find a 1.1-fold change. An AUC of 0.5 indicate
that the spike-in metabolites are distributed randomly among all metabolites. Fold-
changes 2.0 and 4.0 yield high true positive rates of 92% and 96% for a small number
of false positives. This matches sensitivities reported for gene expression data [38].
Figure 3.4: ROC curves for different fold changes (FC). True positive rate (TPR)
and false positive rate (FPR) improve with increasing fold changes.
In Almstetter and Appel et al. [3], the optimal parameter setting is 4 and 0.05 seconds
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for the first and second dimension retention time, and 80% and 20% overlap of m/z
values and relative ion intensities. The alignment matrix has 4404 entries. After
data reduction (candidates detected in at least 50% of all samples) 447 metabolite
candidates remain with 17% zero values.
Compare the peak alignment algorithm to a recently developed software tool
The alignment algorithm INCA and the commercial software tool Statistical Compare
(SC) are validated by the spike-in experiment as described in Section 3.3. The raw
data are preprocessed with software version 4.32. The same preprocessing steps are
chosen for SC and INCA (see Section 3.1). Peak alignment is carried out using first
and second dimension retention times and mass spectra as sort criteria.
The output of SC is transformed to sustain a suitable data matrix for statistical ana-
lysis. The matrix stores the metabolite candidates in the rows and the characteristics
in the columns. An entry is characterized by a peak name, an average and interval of
first and second dimension retention time, an area count, and the m/z 73 peak area
integrals for each measurement. SC alignment generates 887 metabolite candidiates.
Candidates detected in at least 50% of all samples are selected for further analysis.
This peak reduction results in 458 metabolites with a maximum of 14% zero values.
Then, the peak areas are normalized with tridecanoic acid and log transformed.
For the INCA alignment, optimal tolerance parameters are determined using the 20
standard compounds that had been spiked into an E. coli wild type extract. The
optimal parameter setting (see Section 3.3) results in 4404 metabolite candidates
before and 447 metabolites after data reduction. The original number of metabolite
candidates of INCA is much higher (4404) compared to SC (887), but after filtering,
INCA yield a lower number of metabolites (447) than SC (458). INCA aligns all peaks
from the raw peak lists, and thus guarantees that no data are lost. SC excludes peaks
if conflicts in the peak grouping occur. For example, if a metabolite occurs only in
one of two possible pathological conditions this metabolite also will be excluded. The
higher number of metabolites of SC after data reduction is explained by the ability of
SC to access the raw data after alignment to verify quant masses and automatically
assign peak names. The areas for the m/z 73 mass trace of INCA and SC are manually
compared to reconstruct the correct alignment of each spike-in metabolite across all
samples. Only few areas of SC do not match the areas of INCA.
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Figure 3.5: ROC curves after INCA (left) and SC (right) alignment for different
fold changes (FC) and corresponding AUC values. TPR and FPR improve with
increasing fold changes.
The efficiency for detecting fold changes is illustrated in receiver operator character-
istic (ROC) curves. ROC curves for INCA and SC are shown in Figures 3.4 and 3.5.
Both alignment algorithms can not detect a 1.1-fold change. The areas under the
curve (AUC) for INCA and SC are 0.58 and 0.59. A 1.25-fold change is found by
Statistical Compare (AUC of 0.90) more effectively than by INCA (AUC of 0.87).
The AUCs for the 2.5- and 4-fold change are similar. But even the 4-fold change still
yield false positives prior to reaching 100% true positives. In Figure 3.6, the AUCs
for all pairwise fold changes of SC are plotted against the AUCs of INCA. Overall,
SC outperforms INCA in the spike-in experiment.
True changes in metabolite concentration have to be detected against a background
of thousands of spectral signals. Hence, we investigated whether the spike-in fold
changes can be reproduced quantitatively. SC capitalizes on the great advantage of
constantly assigning the same abundant unique mass trace to an identical compound
in different samples. It was not possible to exploit a compound-specific unique mass
for the metabolic fingerprinting with INCA, because we have no access to the raw data
after alignment. Thus, INCA has to rely on the characteristic fragmentation behavior
of trimethylsilyl derivatives upon EI ionization by using only the area integrals for
m/z 73 as a quantitative measure for all peaks.
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Figure 3.6: Area under the curve (AUC) comparison plot between Statistical
Compare and INCA for all pairwise fold changes.
Between expected and observed fold changes of the m/z 73 linear dependencies are
observed. An example, triethanolamine, is shown in Figure 3.7. Corresponding
figures for the other spike-ins can be found in the Appendix A.2. Triethanolamine
quantified by the integral of the m/z 262 (SC) instead of the m/z 73 trace (INCA)
shows a nearly ideal regression line with a slope of 1 and an offset of 0. For all
20 spiked-in metabolites the correlation between observed and expected fold changes
increases when integrating the unique mass trace extracted by SC rather than the m/z
73 fragment ion trace used by INCA. The ranges of regression coefficients improve
from 0.827 - 0.992 to 0.882 - 0.994, the ranges of RSDs from 5.8 - 20.7 % to 4.2 - 20.7
%.
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Figure 3.7: Linear dependency between expected and observed fold changes of
triethanolamine for both (A) the universal m/z 73 fragment ion trace used by
INCA and the analyte specific fragment ion trace m/z 262 extracted by Statist-
ical Compare. All possible pairwise fold changes are plotted.
3.4 Applications
Comparing an E. coli wild type with a mutant strain The metabolic fingerprints
of the E. coli wild type MG1655 and the E. coli MG1655 double-mutant ∆UdhA-
∆PntAB are compared by cultivating each strain in three separate flasks and by
filtrating each culture in triplicates. Nine samples per strain are measured in random
order to avoid a systematic error using GC×GC-TOF-MS.
The data are preprocessed, and combined by INCA using the tolerance parameters
optimized by the spike-in experiment. After alignment, 2259 metabolite candidates
remain. Candidates detected in at least 50% of all samples (9 out of 18) are further
analyzed. This cutoff is selected with respect to the group size of 9 to ensure that
metabolites not present in one group but in the other are not excluded from the
list. After filtering, 25% zero values are among the 398 metabolites. A t-test with
equal variances identifies a list of 48 metabolites that are likely to differ significantly
between the two strains with an estimated false discovery rate of <0.05. In other
words, less than 3 false positives are expected among the 48 identified metabolites.
Among the 48 peaks, 27 true metabolites are identified manually (see Figure 3.8). The
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double mutant strain has a reduced activity of the glycolytic and pentose phosphate
pathways. Biologically, the 27 metabolites make sense since they are all part of these
pathways.
Differential abundant metabolites do not imply that the strains can be correctly
classified into wild type and mutant through their metabolite fingerprints. Thus,
metabolic signatures are learned using the shrunken centroid classifier by Tibshirani
et al. [60]. In a leave-one-out cross-validation procedure, 100% of the metabolic
fingerprints are classified correctly. Most of the compounds are intermediates of the
citrate cycle as expected from previous analysis of the two E. coli strains employ-
ing CE-TOF-MS [61]. The latter method confirmed that the additional differential
abundant metabolites discovered by GC×GC-TOF-MS are true positives.
Comparison of serum versus plasma collection in GC-TOF-MS Bovine serum,
EDTA-plasma and EDTA-plasma fortified with acetylsalicylic acid (ASA) as antiox-
idant are compared with regard to their suitability for metabolomic studies. INCA
was adjusted to align based on one retention time and the tolerances for the mass
spectrum. Metabolic fingerprints are generated from GC-TOF-MS data using the
Leco Chroma- TOF software in combination with the in-house retention time cor-
rection and data alignment tool INCA. A total of 6, 9 and 21 differentially abund-
ant metabolites with a false discovery rate of <0.05 are identified upon comparing
EDTA- versus EDTA-ASA-plasma, EDTA-plasma versus serum and EDTA-ASA-
plasma versus serum, respectively. To confirm that the observed signal intensities
in the GC-TOF-MS fingerprints reflect true metabolite abundances, 19 amino acids,
glucose and 6 organic acids are quantified by means of GC-MS using stable-isotope-
labeled internal standards. As observed with the fingerprints, only the concentrations
of lactate and citrate are found to be significantly lower in EDTA-plasma and serum,
respectively, whereas the concentrations of the other metabolites are similar among
the three sample types investigated.
Details of results and conclusions are found in Dettmer et al. [19].
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Figure 3.8: Metabolite candidates for an FDR < 0.05 identified between an E.
coli wild type and a mutant strain are colored in red or green. The metabolite
is upregulated in the mutant strain if it is colored in red, and downregulated if
it is marked in green.
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3.5 Conclusion and outlook
Before comparing metabolic fingerprints, retention time shifts have to be corrected.
Assuming that the shifts occur linearily across the whole range of the chromatogram,
reference points can be used to fit a linear model for each retention time. However,
it has not been shown yet that retention time shifts always occur linearly. The odd-
numbered fatty acids as reference points cover the entire retention time window.
Thus, they can be used to fit non-linear regression models or linear models locally
like in Wang et al. [65]. First, Wang et al. identify so called landmark peaks across
the whole region of the chromatogram. Then, their algorithm uses a local partial
linear fitting function to interpolate the retention time of non-landmark peaks located
between two landmark peaks in each retention time dimension.
The developed peak alignment module INCA combines peak lists into a single data
matrix based on first and second dimension retention times and spectral informa-
tion. The module is validated by a spike-in experiment. In combination with super-
vised classification algorithms like shrunken centroid classification, GC×GC-TOF-
MS based metabolic fingerprinting provides an effective and simple means to classify
samples according to metabolite abundances making it a valuable tool in medical
diagnosis and prognostication.
The novel Leco ChromaTOF SC algorithm for GC×GC-TOF-MS data is validated
by an spike-in experiment. Results are compared to the developed INCA alignment
tool. The spike-in experiment yields less zero values for the SC as compared to the
INCA alignment. This is caused by the ability of SC to exclude conflicts during
the peak grouping and to access raw data beyond the alignment process. However,
peaks present in one of two possible pathological conditions also will be excluded.
The improvements of alignment and quantification are depicted in ROC curves and
observed-versus-expected fold change plots. Particularly, small fold changes (1.25 -
2.0) show better results with the SC alignment. INCA exploits the characteristic frag-
mentation behavior of silylated metabolites using the universal m/z of 73 as a quant-
itative measure. SC constantly assigns the same unique mass trace to an identical
compound in different samples and use it for quantification. Thus, the extraction of
unique mass traces from mass spectra of aligned metabolites has to be improved for
both, INCA and SC, to make it a better tool for metabolic fingerprinting.
Finally, comprehensive GC×GC-TOF-MS is successfully applied to the metabolic
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fingerprinting of a mutant and a wild type strain of E. coli and INCA is adapted for
GC-TOF-MS data and applied to a serum versus plasma collection.
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A new method for estimating class
probabilities
In the clinical classification of disease we are not only interested in the prediction
of the correct disease type but also in the uncertainties associated with an individual
classification. While the performance of classification algorithms has been analyzed
in great detail, little attention has been given to the usefulness of probability estimates
provided by some classification algorithms. I developed two novel methods for es-
timating smoothed local probabilities (Sections 4.1 and 4.2), and critically compared
them to existing estimation methods on a recently published metabolomics dataset of
patients with kidney disease (Section 4.3).
4.1 Smooth Local Error Frequencies (LEF(Smooth))
A drawback of the binning approach described in Chapter 2.3 is its coarseness. All
cases in a bin receive the same local error frequency estimate Fk(x) regardless where
they fall in the bin, and scores in the same bin can vary substantially. While the
monotone regression step is partly compensating for this artefact, I argue that it
can not fully adjust for the binning effect and more smooth estimates of Fk(xj) are
needed. Next I will describe two modifications of the LEF concept that combine
monotone regression with smooth estimates of local error frequencies.
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The bandwidth λ is the same for all cases xj (one fits all approach). It is a tuning
parameter whose calibration will be discussed in the next section. Note that the
kernels are centered at s(x) and that the classification accuracy of the algorithm for
cases with scores similar to s(x) still determines the local error frequencies. Different
to the binning approach the actual distances of neighboring cases are now taken into
account. Once the local error rates are estimated I proceed like in the binning method
of [71]. I use monotone regression on the Fk(xj) employing the PAVA algorithm
to achieve class probabilities. Figure 4.1A shows class probability functions with
increasing λ indicated by rainbow colors changing from red to violet. The function
with minimal negative log-likelihood of true classes − log(L) and corresponding λ is
chosen (see Figure 4.1B).
This constant λ assumption is problematic if the density of scores s(xj) is far from
uniform. In this case, local error frequency estimates are supported by many scores
in regions where the scores fall densly which makes them reliable, while in less dense
regions estimates are more unreliable. For these situations I propose an adaptive
estimator of Fk(xj).
4.2 Adaptive Local Error Frequencies (LEF(Adapt))











4.2 Adaptive Local Error Frequencies (LEF(Adapt))
Figure 4.1: A Class probability functions for different values of the bandwidth λ of
the gaussian smoothing kernel to estimate local error frequencies LEF(Smooth).
The color changes from red to violet with increasing λ. The black line indicates
the CPF with minimal negative log-likelihood. B The negative log-likelihoods
are plotted for different λs. The dotted line indicates the minimum. C Class
probability functions for different numbers of neighbours to estimated local er-
ror frequencies LEF(Adapt). D Negative log-likelihoods for varying number of
neighbours. The plots are based on a fold of the innermost cross-validation loop
from ADPKD patients (top) and healthy donors (bottom).
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Note that the kernels are centered at s(x) and that their bandwidths depend on a
tuning parameter l and vary across cases. The bandwidth λ is adapted to the local
density of scores around s(x). It is narrower in regions where there are many cases
with similar scores s(xj). I achieve this by setting λ(x, l) equal to the empirical
variance of the l nearest neighbors of s(x). I will discuss tuning of the parameter
l in the next section. The adaptation of the kernel bandwidths ensures that the
local error frequencies are supported by roughly the same number of neighbouring
cases. In addition, the actual similarity of these cases with x is taken into account.
Again, once the local error rates are estimated I proceed as in the binning method of
Zadrozny et al. [71]. I use monotone regression on the Fk(xj) employing the PAVA
algorithm to achieve class probabilities. Figure 4.1C shows class probability functions
with increasing number of neighbours l indicated by rainbow colors changing from red
to violet. The function with minimal negative log-likelihood of true classes − log(L)
and corresponding l is chosen (see Figure 4.1D).
4.3 Comparing probability estimators
The class probability estimators described in Section 2.3 are compared in the context
of a recently published metabolomic profiling study on kidney diseases [27]. Auto-
somal dominant polycystic kidney disease (ADPKD) is a frequent cause of kidney
failure. Due to a lack of reliable laboratory tests early in the disease it is usually
diagnosed at a progressed stage of renal cystic transformation. The study addresses
the challenge to diagnose ADPKD based on metabolomic fingerprints.
The data set comprises 168 urine samples measured using 1D nuclear magnetic reson-
ance (NMR) spectroscopy. 54 samples were obtained from patients with autosomal
polycystic kidney disease. These need to be separated from samples taken from
healthy volunteers (46 samples), and samples from patients with compromised kid-
ney function but no ADPKD (52 samples from diabetes mellitus patients and 16
samples from patients 3 months after renal transplantation). More details on the
composition of cases in the study can be found in Table 4.1. NMR 1D spectra are
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Description Index Size
ADPKD 1 54
ADPKD with medication 1A 35
ADPKD without medication 1B 19
Healthy 2 46
Other CKD
Renal transplant without rejection 3 16
Diabetes with microalbuminuria 4 30
Diabetes without microalbuminuria 5 22
Table 4.1: Patient groups defined within the ADPKD dataset
split into 701 equally sized buckets and globally normalized to the signal of the CH2
group of creatinine to ensure sample to sample comparability. Furthermore compat-
ibility across metabolites is ensured by applying the glog transformation [51]. For
full details of sample preparation and data preprocessing see Gronwald et al. [27].
The focus of this section is the assessment and comparison of class probability function
(CPF) estimators. In the original publications all estimators are used in combination
with different classifier learning algorithms. Heterogeneity of classifiers can severly
confound a comparison of CPF estimators. Moreover, none of the estimators appears
to be tailored to a special classification approach. They can be easily adapted so
that all use the same classification algorithm. Here the popular shrunken centroid
classifier is used [60].
4.3.1 Modification of classification performance
Qualitative classifications can be obtained directly from the linear classifier. No CPF
estimation is necessary. Nevertheless, once a CPF is estimated it is natural to assign
cases with a class probability pk(xj) above 0.5 to class k and those with probabilities
below 0.5 to the other class. This might lead to a reassignment of some cases, as
in the example shown in Figure 4.2 where 14 cases were reassigned. Moreover, since
the sparseness parameter ∆ needs to be calibrated for all estimators independently,
there is an indirect effect of the choice of CPF estimator on the overall classification
performance.
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Figure 4.2: The Figure shows estimated classification probabilities for cross-
validated scores for method LEF(Adapt) exemplarily. The stripes on the x-axis
show the cross-validated classification scores s(xj) from ADPKD patients (top)
and healthy donors (bottom).
Table 4.2 shows the global classification performance in several pairwise classifica-
tions using the plain shrunken centroid classifier (equal to the Naive Bayes (NB)
estimator) and its modifications resulting from the different CPF estimators. Groups
1A and 1B correspond to ADPKD patients with and without medication for arterial
hypertension, group 2 consists of healthy volunteers. Patients 3 months after renal
transplantation without rejection are assigned to group 3 and diabetes mellitus type
2 patients with and without microalbuminuria are in groups 4 and 5, respectively.
For group sizes see Table 4.1. Classification accuracies on the various training sets of
the outer cross-validation loop can be found in the Appendix A.3.1.
The local error frequency method LEF(Adapt) reaches the highest average perform-
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Group comparison Classification performance
NB CB BReg Bin Smooth Adapt
1 2 76.0 75.0 76.0 71.0 74.0 76.0
1 3 97.1 95.7 92.9 97.1 97.1 98.6
1 4 82.1 82.1 85.7 88.1 85.7 85.7
1 5 82.9 88.2 86.8 85.5 84.2 85.5
1 2,3,4,5 75.0 78.6 76.8 76.2 76.8 76.2
1A 2 86.4 86.4 86.4 85.2 80.2 84.0
1B 2 63.1 60.0 66.2 64.7 64.6 66.2
Table 4.2: Classification performances of the outer cross-validation loop for the
six probability estimation methods, Naive Bayes (NB), Compound Bayes (CB),
binary regression (BReg) and the local error frequency methods using binning
(Bin) and smoothing (Smooth/ Adapt). For each patient group comparison
(rows) performances are listed for each estimation method. The assignment of
patient groups to the indices can be found in Table 4.1.
ance of 81.7%, followed by binary regression (BReg) and LEF(Bin) with 81.5% and
81.1% respectively. Overall the classification accuracies of all CPF estimators differ
3.6 to 5.7% depending on the pair of groups. Table 4.2 also shows that the per-
formance of a given method depends on the investigated pair of groups. Therein,
Compound Bayes (CB), binary regression (BReg) and LEF(Adapt) won most fre-
quently.
Gronwald et al. [27] used support vector machines for classification which may ex-
plain the differences in performance. Therefore, we also run the classification using
scores from support vector machines. Therein, the error rates were 5 to 10% smaller
and were comparable to the error rates in Gronwald et al. [27] (see Appendix A.3.2).
4.3.2 Sparseness Bias
As explained above, I optimize the number of classifier features of each CPF estim-
ator seperately. Nevertheless, class probability estimation should be possible for any
number of features. The estimated probabilities should not depend on the number of
features except for reflecting shifts in the overlaps of scores. Figure 4.3 shows discrim-
inant scores and a PAM-based CPF (NB) of a 5 feature and a 200 feature classifier.
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Figure 4.3: Scores of a 5 feature classifier (gray) and a 200 feature estimator
(black) together with a CPF estimated by the PAM approach are shown. Scores
on the x-axis were standardized to mean zero and standard deviation 1 for com-
paring CPFs directly. Cross-validated scores are indicated as gray and black
stripes for the comparison of ADPKD patients (top) and healthy controls (bot-
tom).
In order to ensure comparability, discriminant scores are standardized to mean zero
and standard deviation one. Both refer to a comparison of ADPKD patients with
healthy donors. One can observe that the overlap of scores only marginally changes
for the two classifiers. However the estimated CPFs change dramatically. For the 5
feature curve all patients receive probabilities between 0.35 and 0.70 flagging them all
as unreliable. A result that does not reflect the score distributions well since scores
above +1 are only reached by ADPKD patients and cases with such scores should
be considered reliable ADPKD cases. In contrast, for the 200 metabolites curve all
probabilities are either close to 0 or close to 1. Hence the curve considers all clas-
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sifications reliable, which is misleading given the mix of classes in cases with scores
between −1.1 and +1. The PAM estimator has an obvious sparseness bias. The
more features are included in a classifier the more confident the estimator becomes
regardless of how the classes overlap. I next investigate to which extent the individual
methods suffer from such a sparseness bias.
Figure 4.4 shows scatter plots of estimated probabilities for classifiers including dif-
ferent numbers of metabolites. For each number of features, the class probabilities
of all cases are subtracted by those obtained for the same patient by the 2 feature
classifier. The differences (y-axis) are plotted against the number of features (x-axis,
logarithmic). The density of points in the scatter plots is coded on a blue scale with
dark regions indicating high density. The first plot clearly shows the sparseness bias
of the PAM approach (NB). The 2 gene classifier gives probabilities around 0.5. This
is kept for classifiers up to 10 features. Classifiers with many features produce prob-
abilities near 0 or 1 leading to differences of +/- 0.5. This effect becomes manifest
for classifiers with 75 features or more. None of the other methods showed this be-
havior. Although differences of class probabilities can reach high values, there is no
systematic sparseness bias observable. For the Compound Bayes estimator and the
binary regression estimator the majority of differences stay close to zero. For the local
error rate based methods the differences are greater but also here I do not observe
a systematic trend towards more self-confident probabilities when more features are
included. Another way to look at the sparseness bias is to calculate the difference in
the range for each sample. The distribution of differences are shown as boxplots in
Figure 4.5 for each CPF method.
4.3.3 Calibration
A straight forward criterion to evaluate probability estimators is calibration. An
estimator is well calibrated, if in the long run the relative frequency of true classifica-
tions of cases with estimated class probabilities falling in a small interval [p0−, p0+]
is close to the estimated probability p0 [17]. Our ADPKD data set is not large enough
to test long run performance.
That is why we simulated data with structures similar to the ADPKD data for the
comparison of the ADPKD patients and healthy controls. Therein, pairs of samples
(x1, x2) were drawn randomly from the original data set and sample x1 was shifted
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Figure 4.4: Smoothed scatter plots of estimated probabilities for classifiers in-
cluding different numbers of metabolites. For each patient the class probability
of the 2 feature classifier was subtracted from probabilities for all numbers of
metabolites for the given patient. The differences (y-axis) are plotted against
the number of features (x-axis, logarithmic). The density of points in the scatter
plots is coded on a blue scale with dark regions indicating high density.
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Figure 4.5: Differences in the range of estimated probabilities for classifiers in-
cluding different numbers of metabolites. For each patient the difference in the
range of class probabilities among all numbers of features is calculated. The
distribution of differences (y-axis) is plotted for all CPF methods as boxplots.
on the line spanned by samples x1 and x2 such that x
′
1 = x1 + β · (x2 − x1) where
β ∈ [−1, 1]. This procedure was repeated, for each class separately, as long as the
simulated data set was of the same size as the original one. Finally, 30 data sets were
used for further analyses. Because the distances of the new data points were smaller
within classes and larger between classes compared to the original data, learning a
classifier was easier and the misclassification rate decreased by more than 10%. With
decreasing learning complexity the classification probabilities tend to zero and one.
This was compensated by drawing samples from the data set with probability of 99%
for the currently simulated class.
Figure 4.6 compares estimated class probabilities to long run classification accuracies.
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Figure 4.6: Estimated class probabilities to long run classification accuracies are
shown in a reliability diagram. Both estimated error probabilities (x-axis) and
observed error frequencies (y-axis) were collected in bins of width 0.1. If the clas-
sifier is well calibrated, all points fall close to the x = y line. Root mean square
errors (RMSE) from this line quantify the calibration quality of the estimator.
Both estimated error probabilities and observed error frequencies were collected in
bins of width 0.1. If the classifier is well calibrated, all points fall close to the x = y
line. Root mean square errors (RMSE) from this line quantify the calibration of
the estimator. I found that the RMSE was large for the Compound Bayes estim-
ator and for binary regression while it was decreased by a factor of up to 6 for the
local estimation methods, indicating that the local estimators are better calibrated.
To test whether calibration depends on the number of samples used for estimator
training, I rerun our evaluation for sample sizes between 100 and 3200. Figure 4.7
shows that in the study the RMSE values remain relatively constant, and that local
estimators outperform the competing methods independent of the sample size, con-
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Figure 4.7: Calibration of CPFs with increasing sample size. To test whether
calibration depends on the number of samples used for estimator training, the
evaluation of calibration was repeated for sample sizes between 100 and 3200
and RMSEs were plotted for all CPFs with increasing sample size.
trary to Niculescu-Mizil et al. [47] who report a superior performance of the binary
regression estimator for data sets with less than 1000 samples in the domain of text
classification.
4.3.4 Variance of estimators
Another classical criterion for estimator evaluation is the variance of the estimator
with respect to sampling. Typically, flexibility of an estimator comes at the price of
increased variance. The binary regression approach is the most rigid in our collection
with only two adjustable parameters. Compound Bayes has four parameters, while
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the non-parametric local estimators seem to be the most flexible ones. Here I assess
the variance of probability estimators across multiple simulation runs. For this pur-
pose the original data of ADPKD patients and healthy controls were enclosed as test
set in the outer loop of the cross-validation scheme within all simulation runs (from
Section 4.3.3). Hence, each case was predicted number of outer folds times simulated
data sets for each CPF method. For each fold a variance was calculated for each case
among simulations. Finally, the median variance of each case among folds and meth-
ods was evaluated. Thus, I assess the variance for each sample individually. Figure
4.8 shows box plots of the variance of estimated class probabilities across all samples.
I observed, that the variance was smallest for the binary regression estimator followed
by the Compound Bayes method and larger for the local error estimators, which is
not surprising given the increased flexibility of these estimators. Moreover, I observed
that the local estimators displayed a wider range of variances across samples showing
high variance for samples in the gray zones between classes.
4.3.5 Identifying reliable classifications
The ultimate goal of class probability estimation is the identification of those samples
that can be reliably classified. Misclassifications should be rare among samples with
high class probabilities. This property of an estimator is related to calibration in
that I relate long run misclassification rates with estimated probabilities. However,
the focus here is on extreme probabilities only. If an estimator is poorly calibrated
for probabilities around 0.5 this is less of a problem since clinicians would not base
treatment decisions on classifications that are labeled unreliable. If however, an
estimated probability is close to 1, it must be reliable since a clinician might want
to adjust treatment decisions based on this diagnostic result. Moreover, there is a
trade-off between the reliability of a diagnosis and the number of samples that receive
class probabilities close to 1. An estimator might assign extreme probabilities only to
a small number of cases thus obtaining very low misclassification rates among these
cases. However, this estimator might also miss many cases that could actually be
reliably classified. Figure 4.9 shows the trade-off between the percentage of correct
classifications and unclassified cases. Therein, a confidence threshold α is varied
from 0.5 to 1. Samples below the threshold are left unclassified (x-axis), whereas the
percentage of correct classifications is computed among samples above α (y-axis).
I observed that the percentage of correct classifications of the local methods does not
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Figure 4.8: Variance of probability estimators across multiple simulation runs.
Original data of ADPKD patients and healthy controls were enclosed as test
set in the outer loop of the cross-validation scheme within all simulation runs.
Each case was predicted number of outer folds times simulated data sets for
each CPF method. For each fold a variance was calculated for each case among
simulations. Finally, the median variance of each case among folds and methods
was used for plotting.
fluctuate as much as that of the Compound Bayes and binary regression. Furthermore,
the local methods reached 100% correct classifications faster than the others. For
α = 0.90 (indicated by the vertical dashed lines in Figure 4.9), Compound Bayes left
76% of samples unclassified with 87.5% correct classifications, 2.5% below the con-
fidence level, and binary regression left 85% unclassified being 100% sensitive. The
local methods left 78 - 81% cases unclassified and classified the remaining samples
correctly.
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Figure 4.9: Reliability of classifications with increasing confidence level α. α is
varied from 0.5 to 1 estimated probability. Samples below the threshold are left
unclassified (x-axis), whereas the percentage of correct classifications is com-
puted among samples above α (y-axis). The vertical dashed lines indicate the
90% confidence level for the different CPF estimators.
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4.4 Conclusions and outlook
Before a clinician decides on the treatment of a patient, the reliability of the dia-
gnosis must be known. In machine learning reliability can be expressed in terms of
classification probabilities. Since little attention has been given to the usefulness of
probability estimates so far, I have compared a selection of class probability estimat-
ors including Bayes methods, binary regression and local error based methods in the
context of metabolomics based diagnosis of disease. I found that local error based
estimators perform superior for instance to more widely used methods, the PAM
program, binary regression and Compound Bayes classifiers. Strikingly, the PAM
approach displayed a strong sparseness bias. I do not recommend its use in clinical
diagnosis at all. Binary regression based estimators display the least variance but are
inferior with respect to all other criteria evaluated here. A collection of three local
error based estimators performed best overall with only marginal differences between
the individual implementations. I conclude that this type of approach is the method
of choice.
I evaluated class probabilities for binary decisions. However, clinical diagnosis in-
cludes more possible entities. Statnikov et al. [59] have evaluated a number of
multi-classification algorithms for gene expression data. They report classification
accuracies between 70% and 80% when trying to distinguish up to 14 different tumor
types. They also observe that the more disease types considered in a classification
task, the more difficult the classification is. Mukherjee [45] argues that in problems
with more classes, the classification algorithm has to determine a larger number of
separation boundaries. A common approach for constructing a multi-class classifier
is to determine separation boundaries between each pair of classes using a two-class
classification algorithm and integrate the results to generate a single classification.
Hastie et al. [33] suggest a coupling scheme to summarize pairwise class probabilities
into a class probability per class for the given sample.
The ADPKD patients of the metabolomics dataset are grouped into patients with
and without medication. These two groups can not be separated by a classifier
(classification accuracies not shown). In a multi-class setting these groups lower the
overall classification accuracy.
Future work could improve multi-class classification by either merging undistinguish-
able classes as long as this leads to an overall gain in accuracy, or reject classification
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in case of doubt. New patients may be borderline as well as do not belong to any
class used for training. Hanczar and Dougherty [32] reject patient samples such that
the overall classification accuracy satisfies the user-defined accuracy. This approach




A.1 Probability transformation of Naive Bayes (NB)
estimates






− 2 · logpik
is calculated independently for each class, where the sum runs over all genes with
non-zero weights after shrinkage ∆, σi is the pooled within-class standard deviation
of gene i and pik the estimated proportion of cases from class k in the entire pop-
ulation. A case is then assigned to the group k with minimal δk(x). Classification
probabilities are also derived from the δk(x) by assuming independence and normality
with equal within classes variance of all p classifier genes. Under these assumptions













Note that the nearest shrunken centroid classification rule defines a separating hy-
perplane with normal vector wi =
2·(x¯i1−x¯i2)
σ2i










Proof of Equation A.2:















·(d2(x)− d1(x))︸ ︷︷ ︸ .
























































The last line implies a hyperplane with normal vector w and distance to the origin
b.
























































































































































































































y = 0.704x + 0.277
r = 0.954



































































































































































y = 0.791x + 0.191
r = 0.984







































































































































































































y = 0.443x + 0.523
r = 0.917



















































































































































y = 0.735x + 0.24
r = 0.985
mean RSD = 7.8





































































































































































y = 0.288x + 0.678
r = 0.878































































































































































y = 0.398x + 0.562
r = 0.932





























































































































































y = 0.337x + 0.626
r = 0.914





































































































y = 0.45x + 0.508
r = 0.975
























































































































































































































































































y = 0.798x + 0.195
r = 0.934































































































































































y = 1.074x + −0.063
r = 0.993




















































































































































































































































































































































































































































































y = 0.977x + 0.127
r = 0.63












































































































































































































































y = 0.621x + 0.352
r = 0.933
mean RSD = 14.9
































































































































































































































































































y = 0.586x + 0.395
r = 0.857












































































































































































































y = 0.364x + 0.603
r = 0.874












































































































































































































































































































y = 0.521x + 0.475
r = 0.797

























































































































































































































































y = 0.939x + 0.07
r = 0.949







































































































































































































































y = 0.521x + 0.453
r = 0.908























































































































































































































































y = 0.756x + 0.23
r = 0.954











































































































































































































































































y = 0.503x + 0.48
r = 0.843






























































































































































































































































































y = 0.836x + 0.161
r = 0.936
mean RSD = 18
















































































































































































































































y = 0.873x + 0.124
r = 0.955




















































































































































































































































































y = 1.015x + 0.005
r = 0.915






















































































































































































































y = 0.613x + 0.357
r = 0.959






























































































































































































































y = 0.849x + 0.14
r = 0.973
































































































































































































































y = 0.259x + 0.715
r = 0.782














































































































































































































y = 0.38x + 0.585
r = 0.903
























































































































































































































































































































































y = 0.881x + 0.134
r = 0.907






















































































































































































































































































y = 0.986x + 0.023
r = 0.958
mean RSD = 16.2



















































































































































































































































y = 0.623x + 0.363
r = 0.904








































































































































































































































y = 0.793x + 0.194
r = 0.962









































































































































































































































y = 0.982x + 0.022
r = 0.976






















































































































































































































y = 1.083x + −0.07
r = 0.984



































































































































































y = 0.721x + 0.254
r = 0.985































































































































































































y = 0.946x + 0.053
r = 0.986





























































































































































































































































y = 1.115x + −0.094
r = 0.972














































































































































































































































y = 1.066x + −0.052
r = 0.977
mean RSD = 12.5






































































































































































































































y = 0.885x + 0.11
r = 0.971














































































































































































































































y = 0.952x + 0.051
r = 0.971














































































































































































































































































































y = 0.838x + 0.159
r = 0.928































































































































































































y = 0.863x + 0.126
r = 0.983
mean RSD = 9.5
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A.3 Average classification accuracies of the outer
cross-validation loop








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































A.3 Average classification accuracies of the outer cross-validation loop
Group comparison Classification performance
NB CB BReg Bin Smooth Adapt
1 2 78.0 80.0 80.0 78.0 77.0 79.0
1 3 7.1 97.1 97.1 75.7 75.7 75.7
1 4 94.0 89.3 91.7 91.7 91.7 86.9
1 5 90.8 92.1 94.7 90.8 89.5 90.8
1 2,3,4,5 78.6 77.4 81.0 76.8 79.8 75.6
1A 2 88.9 90.0 88.9 85.1 88.9 86.4
1B 2 72.3 69.2 80.0 73.8 70.8 70.8
Table A.3: Classification performances of the outer cross-validation loop for the six
probability estimation methods based on SVM scores. For each patient group
comparison (rows) performances are listed for each estimation method. The
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